ݺߣshows by User: ssuser3eb8d64 / http://www.slideshare.net/images/logo.gif ݺߣshows by User: ssuser3eb8d64 / Sat, 01 Aug 2015 06:58:44 GMT ݺߣShare feed for ݺߣshows by User: ssuser3eb8d64 Antiretroviral intensification to prevent intrapartum HIV transmission in late comers /slideshow/moac02-phpt-520july15version-3-m-lallemant/51164223 moac02phpt-520-july-15version3mlallemant-150801065844-lva1-app6892
Lallemant M. и др. «Antiretroviral intensification to prevent intrapartum HIV transmission in late comers» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2015), Vancouver, 2015. MOAC0204.]]>
Lallemant M. и др. «Antiretroviral intensification to prevent intrapartum HIV transmission in late comers» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2015), Vancouver, 2015. MOAC0204.]]> Sat, 01 Aug 2015 06:58:44 GMT /slideshow/moac02-phpt-520july15version-3-m-lallemant/51164223 ssuser3eb8d64@slideshare.net(ssuser3eb8d64) Antiretroviral intensification to prevent intrapartum HIV transmission in late comers ssuser3eb8d64 Lallemant M. и др. «Antiretroviral intensification to prevent intrapartum HIV transmission in late comers» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2015), Vancouver, 2015. MOAC0204. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/moac02phpt-520-july-15version3mlallemant-150801065844-lva1-app6892-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Lallemant M. и др. «Antiretroviral intensification to prevent intrapartum HIV transmission in late comers» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2015), Vancouver, 2015. MOAC0204.
Antiretroviral intensification to prevent intrapartum HIV transmission in late comers from Илья Антипин
]]> 547 5 https://cdn.slidesharecdn.com/ss_thumbnails/moac02phpt-520-july-15version3mlallemant-150801065844-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Raltegravir for prevention of mother-to-child transmission of HIV /slideshow/raltegravir-for-prevention-of-mothertochild-transmission-of-hiv/51164166 ias2015med2-150801065453-lva1-app6891
Trahan M.J. (докладчик Kakkar F.) «Raltegravir for prevention of mother-to-child transmission of HIV» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2015), Vancouver, 2015. TUAB0105.]]>
Trahan M.J. (докладчик Kakkar F.) «Raltegravir for prevention of mother-to-child transmission of HIV» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2015), Vancouver, 2015. TUAB0105.]]> Sat, 01 Aug 2015 06:54:53 GMT /slideshow/raltegravir-for-prevention-of-mothertochild-transmission-of-hiv/51164166 ssuser3eb8d64@slideshare.net(ssuser3eb8d64) Raltegravir for prevention of mother-to-child transmission of HIV ssuser3eb8d64 Trahan M.J. (докладчик Kakkar F.) «Raltegravir for prevention of mother-to-child transmission of HIV» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2015), Vancouver, 2015. TUAB0105. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ias2015med2-150801065453-lva1-app6891-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Trahan M.J. (докладчик Kakkar F.) «Raltegravir for prevention of mother-to-child transmission of HIV» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2015), Vancouver, 2015. TUAB0105.
Raltegravir for prevention of mother-to-child transmission of HIV from Илья Антипин
]]> 2541 16 https://cdn.slidesharecdn.com/ss_thumbnails/ias2015med2-150801065453-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 High efficacy of grazoprevir/elbasvir in HCV genotype 1, 4, and 6-infected patients with HIV co-infection: the phase 3 C-EDGE co-infection study /ssuser3eb8d64/high-efficacy-of-grazoprevirelbasvir-in-hcv-genotype-1-4-and-6infected-patients-with-hiv-coinfection-the-phase-3-cedge-coinfection-study finalc-edgehivias15jul0720150915-150731022139-lva1-app6892
Rockstroh J. и др. «High efficacy of grazoprevir/elbasvir in HCV genotype 1, 4, and 6-infected patients with HIV co-infection: the phase 3 C-EDGE co-infection study» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, 2015. TUAB0206.]]>
Rockstroh J. и др. «High efficacy of grazoprevir/elbasvir in HCV genotype 1, 4, and 6-infected patients with HIV co-infection: the phase 3 C-EDGE co-infection study» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, 2015. TUAB0206.]]> Fri, 31 Jul 2015 02:21:39 GMT /ssuser3eb8d64/high-efficacy-of-grazoprevirelbasvir-in-hcv-genotype-1-4-and-6infected-patients-with-hiv-coinfection-the-phase-3-cedge-coinfection-study ssuser3eb8d64@slideshare.net(ssuser3eb8d64) High efficacy of grazoprevir/elbasvir in HCV genotype 1, 4, and 6-infected patients with HIV co-infection: the phase 3 C-EDGE co-infection study ssuser3eb8d64 Rockstroh J. и др. «High efficacy of grazoprevir/elbasvir in HCV genotype 1, 4, and 6-infected patients with HIV co-infection: the phase 3 C-EDGE co-infection study» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, 2015. TUAB0206. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/finalc-edgehivias15jul0720150915-150731022139-lva1-app6892-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Rockstroh J. и др. «High efficacy of grazoprevir/elbasvir in HCV genotype 1, 4, and 6-infected patients with HIV co-infection: the phase 3 C-EDGE co-infection study» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, 2015. TUAB0206.
High efficacy of grazoprevir/elbasvir in HCV genotype 1, 4, and 6-infected patients with HIV co-infection: the phase 3 C-EDGE co-infection study from Илья Антипин
]]> 1093 7 https://cdn.slidesharecdn.com/ss_thumbnails/finalc-edgehivias15jul0720150915-150731022139-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 High SVR rates in HCV/HIV-1 co-infected patients regardless of baseline characteristics /slideshow/high-svr-rates-in-hcvhiv1-coinfected-patients-regardless-of-baseline-characteristics/51123425 ias15turquoise-isubgroupspresented-150731022039-lva1-app6891
Wyles D и др. «High SVR rates in HCV/HIV-1 co-infected patients regardless of baseline characteristics» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, 2015. TUAB0203.]]>
Wyles D и др. «High SVR rates in HCV/HIV-1 co-infected patients regardless of baseline characteristics» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, 2015. TUAB0203.]]> Fri, 31 Jul 2015 02:20:39 GMT /slideshow/high-svr-rates-in-hcvhiv1-coinfected-patients-regardless-of-baseline-characteristics/51123425 ssuser3eb8d64@slideshare.net(ssuser3eb8d64) High SVR rates in HCV/HIV-1 co-infected patients regardless of baseline characteristics ssuser3eb8d64 Wyles D и др. «High SVR rates in HCV/HIV-1 co-infected patients regardless of baseline characteristics» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, 2015. TUAB0203. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ias15turquoise-isubgroupspresented-150731022039-lva1-app6891-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Wyles D и др. «High SVR rates in HCV/HIV-1 co-infected patients regardless of baseline characteristics» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, 2015. TUAB0203.
High SVR rates in HCV/HIV-1 co-infected patients regardless of baseline characteristics from Илья Антипин
]]> 494 7 https://cdn.slidesharecdn.com/ss_thumbnails/ias15turquoise-isubgroupspresented-150731022039-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1 /slideshow/ledipasvirsofosbuvir-for-12-weeks-in-patients-coinfected-with-hcv-and-hiv1/51123404 ias2015cooperion-4finalnejmupdatedv1-150731021934-lva1-app6892
Naggie S. И др. (докладчик Cooper.) «Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, 2015. TUAB0202.]]>
Naggie S. И др. (докладчик Cooper.) «Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, 2015. TUAB0202.]]> Fri, 31 Jul 2015 02:19:34 GMT /slideshow/ledipasvirsofosbuvir-for-12-weeks-in-patients-coinfected-with-hcv-and-hiv1/51123404 ssuser3eb8d64@slideshare.net(ssuser3eb8d64) Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1 ssuser3eb8d64 Naggie S. И др. (докладчик Cooper.) «Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, 2015. TUAB0202. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ias2015cooperion-4finalnejmupdatedv1-150731021934-lva1-app6892-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Naggie S. И др. (докладчик Cooper.) «Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1» 8th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, Vancouver, 2015. TUAB0202.
Ledipasvir/sofosbuvir for 12 weeks in patients co-infected with HCV and HIV-1 from Илья Антипин
]]> 819 7 https://cdn.slidesharecdn.com/ss_thumbnails/ias2015cooperion-4finalnejmupdatedv1-150731021934-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 HPTN 067/ADAPT methods and results from women in Cape Town /slideshow/hptn-067adapt-methods-and-results-from-women-in-cape-town/51082593 bobgranthptn067intro-150730023513-lva1-app6891
Grant R. и др. «HPTN 067/ADAPT methods and results from women in Cape Town» 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, 2015. MOSY0103. ]]>
Grant R. и др. «HPTN 067/ADAPT methods and results from women in Cape Town» 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, 2015. MOSY0103. ]]> Thu, 30 Jul 2015 02:35:13 GMT /slideshow/hptn-067adapt-methods-and-results-from-women-in-cape-town/51082593 ssuser3eb8d64@slideshare.net(ssuser3eb8d64) HPTN 067/ADAPT methods and results from women in Cape Town ssuser3eb8d64 Grant R. и др. «HPTN 067/ADAPT methods and results from women in Cape Town» 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, 2015. MOSY0103. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/bobgranthptn067intro-150730023513-lva1-app6891-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Grant R. и др. «HPTN 067/ADAPT methods and results from women in Cape Town» 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, 2015. MOSY0103.
HPTN 067/ADAPT methods and results from women in Cape Town from Илья Антипин
]]> 459 6 https://cdn.slidesharecdn.com/ss_thumbnails/bobgranthptn067intro-150730023513-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 HPTN 067/ADAPT study: a comparison of daily and intermittent pre-exposure prophylaxis (PrEP) dosing for HIV prevention in men who have sex with men and transgender women in New York city /slideshow/hptn-067adapt-study-a-comparison-of-daily-and-intermittent-preexposure-prophylaxis-prep-dosing-for-hiv-prevention-in-men-who-have-sex-with-men-and-transgender-women-in-new-york-city/51082556 harlemhptn067ias2015presentationupdated071815lb-150730023323-lva1-app6891
Mannheimer S. и др. «HPTN 067/ADAPT study: a comparison of daily and intermittent pre-exposure prophylaxis (PrEP) dosing for HIV prevention in men who have sex with men and transgender women in New York city» 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, 2015. MOAC0305LB.]]>
Mannheimer S. и др. «HPTN 067/ADAPT study: a comparison of daily and intermittent pre-exposure prophylaxis (PrEP) dosing for HIV prevention in men who have sex with men and transgender women in New York city» 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, 2015. MOAC0305LB.]]> Thu, 30 Jul 2015 02:33:23 GMT /slideshow/hptn-067adapt-study-a-comparison-of-daily-and-intermittent-preexposure-prophylaxis-prep-dosing-for-hiv-prevention-in-men-who-have-sex-with-men-and-transgender-women-in-new-york-city/51082556 ssuser3eb8d64@slideshare.net(ssuser3eb8d64) HPTN 067/ADAPT study: a comparison of daily and intermittent pre-exposure prophylaxis (PrEP) dosing for HIV prevention in men who have sex with men and transgender women in New York city ssuser3eb8d64 Mannheimer S. и др. «HPTN 067/ADAPT study: a comparison of daily and intermittent pre-exposure prophylaxis (PrEP) dosing for HIV prevention in men who have sex with men and transgender women in New York city» 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, 2015. MOAC0305LB. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/harlemhptn067ias2015presentationupdated071815lb-150730023323-lva1-app6891-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Mannheimer S. и др. «HPTN 067/ADAPT study: a comparison of daily and intermittent pre-exposure prophylaxis (PrEP) dosing for HIV prevention in men who have sex with men and transgender women in New York city» 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, 2015. MOAC0305LB.
HPTN 067/ADAPT study: a comparison of daily and intermittent pre-exposure prophylaxis (PrEP) dosing for HIV prevention in men who have sex with men and transgender women in New York city from Илья Антипин
]]> 592 11 https://cdn.slidesharecdn.com/ss_thumbnails/harlemhptn067ias2015presentationupdated071815lb-150730023323-lva1-app6891-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 HPTN 067/ADAPT study: a comparison of daily and non-daily pre-exposure prophylaxis dosing in Thai men who have sex with men, Bangkok, Thailand /slideshow/hptn-067adapt-study-a-comparison-of-daily-and-nondaily-preexposure-prophylaxis-dosing-in-thai-men-who-have-sex-with-men-bangkok-thailand/51082524 hptn067bkkias2015presentation-150730023137-lva1-app6892
Holtz TH и др. «HPTN 067/ADAPT study: a comparison of daily and non-daily pre-exposure prophylaxis dosing in Thai men who have sex with men, Bangkok, Thailand» 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, 2015. MOAC0306LB. ]]>
Holtz TH и др. «HPTN 067/ADAPT study: a comparison of daily and non-daily pre-exposure prophylaxis dosing in Thai men who have sex with men, Bangkok, Thailand» 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, 2015. MOAC0306LB. ]]> Thu, 30 Jul 2015 02:31:37 GMT /slideshow/hptn-067adapt-study-a-comparison-of-daily-and-nondaily-preexposure-prophylaxis-dosing-in-thai-men-who-have-sex-with-men-bangkok-thailand/51082524 ssuser3eb8d64@slideshare.net(ssuser3eb8d64) HPTN 067/ADAPT study: a comparison of daily and non-daily pre-exposure prophylaxis dosing in Thai men who have sex with men, Bangkok, Thailand ssuser3eb8d64 Holtz TH и др. «HPTN 067/ADAPT study: a comparison of daily and non-daily pre-exposure prophylaxis dosing in Thai men who have sex with men, Bangkok, Thailand» 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, 2015. MOAC0306LB. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/hptn067bkkias2015presentation-150730023137-lva1-app6892-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Holtz TH и др. «HPTN 067/ADAPT study: a comparison of daily and non-daily pre-exposure prophylaxis dosing in Thai men who have sex with men, Bangkok, Thailand» 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Vancouver, 2015. MOAC0306LB.
HPTN 067/ADAPT study: a comparison of daily and non-daily pre-exposure prophylaxis dosing in Thai men who have sex with men, Bangkok, Thailand from Илья Антипин
]]> 552 7 https://cdn.slidesharecdn.com/ss_thumbnails/hptn067bkkias2015presentation-150730023137-lva1-app6892-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Профилактика профессионального инфицирования ВИЧ �медицинских работников�� /slideshow/uljanovsk-2014-prof/43621300 uljanovsk2014prof-150117164020-conversion-gate02
ГУЗ Центр СПИД, заведующая эпидемиологическим отделением Гришкеева Е.А. 2014. г. Ульяновск.]]>
ГУЗ Центр СПИД, заведующая эпидемиологическим отделением Гришкеева Е.А. 2014. г. Ульяновск.]]> Sat, 17 Jan 2015 16:40:20 GMT /slideshow/uljanovsk-2014-prof/43621300 ssuser3eb8d64@slideshare.net(ssuser3eb8d64) Профилактика профессионального инфицирования ВИЧ �медицинских работников�� ssuser3eb8d64 ГУЗ Центр СПИД, �заведующая эпидемиологическим отделением Гришкеева Е.А.� 2014. г. Ульяновск. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/uljanovsk2014prof-150117164020-conversion-gate02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> ГУЗ Центр СПИД, �заведующая эпидемиологическим отделением Гришкеева Е.А.� 2014. г. Ульяновск.
Профилактика профессионального инфицирования ВИЧ медицинских работников from Илья Антипин
]]> 874 1 https://cdn.slidesharecdn.com/ss_thumbnails/uljanovsk2014prof-150117164020-conversion-gate02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 HAART-adherence /ssuser3eb8d64/haartadherence ver2-101020204200-phpapp02
Презентация на тему приверженности АРВ-терапии]]>
Презентация на тему приверженности АРВ-терапии]]> Wed, 20 Oct 2010 20:41:48 GMT /ssuser3eb8d64/haartadherence ssuser3eb8d64@slideshare.net(ssuser3eb8d64) HAART-adherence ssuser3eb8d64 Презентация на тему приверженности АРВ-терапии <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ver2-101020204200-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Презентация на тему приверженности АРВ-терапии
HAART-adherence from Илья Антипин
]]> 323 1 https://cdn.slidesharecdn.com/ss_thumbnails/ver2-101020204200-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-ssuser3eb8d64-48x48.jpg?cb=1607960938 arvt.ru https://cdn.slidesharecdn.com/ss_thumbnails/moac02phpt-520-july-15version3mlallemant-150801065844-lva1-app6892-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/moac02-phpt-520july15version-3-m-lallemant/51164223 Antiretroviral intensi... https://cdn.slidesharecdn.com/ss_thumbnails/ias2015med2-150801065453-lva1-app6891-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/raltegravir-for-prevention-of-mothertochild-transmission-of-hiv/51164166 Raltegravir for preven... https://cdn.slidesharecdn.com/ss_thumbnails/finalc-edgehivias15jul0720150915-150731022139-lva1-app6892-thumbnail.jpg?width=320&height=320&fit=bounds ssuser3eb8d64/high-efficacy-of-grazoprevirelbasvir-in-hcv-genotype-1-4-and-6infected-patients-with-hiv-coinfection-the-phase-3-cedge-coinfection-study High efficacy of grazo...